1887

Abstract

Summary

The anticholinergic anti-parkinsonism drug Norakin is an inhibitor of influenza virus multiplication. By crossing a Norakin-resistant variant of fowl plague virus (FPV) strain Weybridge with the sensitive FPV/Rostock/34 wild-type virus, Norakin-resistant recombinants were obtained. Analyses of the gene composition showed that all Norakin-resistant recombinants had inherited their haemagglutinin gene from the Norakin-resistant parent strain. The majority of the recombinants had received all the other gene segments from the sensitive parent strain. Norakin was shown to inhibit red blood cell lysis induced either by purified virions or by the haemagglutinin of a sensitive FPV strain at low pH, but failed to affect the Norakin-resistant FPV variant. No aggregation of autoliposomes containing the haemagglutinin of a sensitive FPV strain or digestion of the HA1 subunit of haemagglutinin by trypsin occurred in the presence of Norakin at acid pH. The data suggest that the haemagglutinin of FPV is the target for the antiviral activity of Norakin, which acts by inhibiting the conformational change in the haemagglutinin at acid pH important for lysis.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-67-6-1115
1986-06-01
2021-08-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/67/6/JV0670061115.html?itemId=/content/journal/jgv/10.1099/0022-1317-67-6-1115&mimeType=html&fmt=ahah

References

  1. Appleyard G. 1977; Amantadine-resistance as a genetic marker for influenza viruses. Journal of General Virology 36:249–255
    [Google Scholar]
  2. Daniels R. S., Douglas A. R., Skehel J. J., Wiley D. C. 1983; Analysis of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. Journal of General Virology 64:1657–1662
    [Google Scholar]
  3. Ghendon Y., Klimov A., Blagoveshenskaya O., Ghenkina D. 1979; Investigation of recombinants of human influenza and fowl plague viruses. Journal of General Virology 43:183–191
    [Google Scholar]
  4. Hay A. J., Bellamy A. R., Abraham G., Skehel J. J., Brand C. M., Webster R. G. 1977a; Procedures for characterization of the genetic material of candidate vaccine strains. Developments in Biological Standardization 39:15–24
    [Google Scholar]
  5. Hay A. J., Lomniczi B., Bellamy A. R., Skehel J. J. 1977b; Transcription of the influenza virus genome. Virology 83:337–345
    [Google Scholar]
  6. Hosaka Y., Yasuda Y., Fukai K. 1983; Hemolysis by liposomes containing influenza virus haemagglutinins. Journal of Virology 46:1014–1017
    [Google Scholar]
  7. Kawasaki K., Sato S. B., Ohnishi S. 1983; Membrane fusion activity of reconstituted vesicles of influenza virus haemagglutinin glycoproteins. Biochimica et biophysica acta 733:286–290
    [Google Scholar]
  8. Lenard J., Bailey C. A., Miller D. K. 1982; pH dependence of influenza A virus-induced haemolysis is determined by the haemagglutinin gene. Journal of General Virology 62:353–355
    [Google Scholar]
  9. Maeda T., Kawasaki K., Ohnishi S. 1981; Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proceedings of the National Academy of Sciences, U,. S,. A 78:4133–4137
    [Google Scholar]
  10. Markushin S. G., Isachenko V. A., Molibog E. V., Zakstelskaya L. Ya., Ghendon Y. Z. 1981; Gene homology and antigenic specificity of envelope proteins of avian influenza virus strains possessing haemagglutinin Havl. Acta virologica 25:65–70
    [Google Scholar]
  11. Presber H. W., Schroeder C., Hegenscheid B., Heider H., Reefschlager J., Rosenthal H. A. 1984; Antiviral activity of NorakinR (triperiden) and related anticholinergic anti-Parkinson drugs. Acta virologica 28:501–507
    [Google Scholar]
  12. Sato B. S., Kawasaki K., Ohnishi S. 1983; Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments. Proceedings of the National Academy of Sciences, U,. S,. A 80:3153–3157
    [Google Scholar]
  13. Skehel J. J., Bayley P. M., Brown E. G., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. 1982; Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proceedings of the National Academy of Sciences, U,. S,. A 79:968–972
    [Google Scholar]
  14. Vernier V. G. 1981; Antiparkinsonism drugs. Burger’s Medicinal Chemistry II pp 413–430 4th edn Edited by Wolff M. E. New York: John Wiley and Sons;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-67-6-1115
Loading
/content/journal/jgv/10.1099/0022-1317-67-6-1115
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error